ArticleBMC pharmacology & toxicology2024

Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data.

Akira Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.